-
21.发明申请D-SERINE TRANSPORTER INHIBITORS AS PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VISUAL SYSTEM DISORDERS 有权D-丝氨酸转运蛋白抑制剂作为治疗视力系统疾病的药物组合物公开(公告)号：US20140221453A1
公开(公告)日：2014-08-07
申请号：US14248228
申请日：2014-04-08
申请人： Allergan, Inc.
IPC分类号： A61K31/401 , A61K31/197 , A61K31/198
CPC分类号： A61K31/197 , A61K31/196 , A61K31/198 , A61K31/216 , A61K31/401 , A61K31/405 , A61K45/06 , A61K2300/00
摘要： The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment of visual system disorders and the enhancement of the visual function.
摘要翻译： 本发明涉及包含D-丝氨酸转运蛋白抑制剂的药物组合物和使用这种药物组合物在治疗视觉系统障碍和增强视觉功能的方法中的治疗方法。
-
22.发明授权Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators 有权作为甲酰肽受体1（FPRL-1）受体调节剂的N-脲取代氨基酸的酰胺衍生物公开(公告)号：US08658803B2
公开(公告)日：2014-02-25
申请号：US13658523
申请日：2012-10-23
申请人： Allergan, Inc.
IPC分类号： C07C275/30 , C07C317/42 , C07C323/44 , C07D233/64 , C07D209/20 , C07C323/60 , C07C317/50
CPC分类号： A61K31/417 , A61K31/17 , A61K31/197 , A61K31/198 , A61K31/216 , A61K31/4045 , C07C275/30 , C07C317/42 , C07C317/50 , C07C323/44 , C07C323/60 , C07D209/20 , C07D233/64 , C07K5/06017 , C07K5/06034 , C07K5/06052 , C07K5/0606 , C07K5/06113 , C07K5/06147 , C07K5/06156 , Y02A50/401
摘要： The present invention relates to novel amide derivatives of N-urea substituted amino acids, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of the N-formyl peptide receptor like-1 (FPRL-1) receptor.
摘要翻译： 本发明涉及N-脲取代氨基酸的新型酰胺衍生物，其制备方法，含有它们的药物组合物及其作为N-甲酰基肽受体1（FPRL-1）受体调节剂的药物的用途。
-
23.发明申请ARYL UREA DERIVATIVES AS N-FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS 有权作为N-甲基肽受体样-1（FPRL-1）受体调节剂的ARYL UREA衍生物公开(公告)号：US20130331570A1
公开(公告)日：2013-12-12
申请号：US13966558
申请日：2013-08-14
申请人： Allergan, Inc.
IPC分类号： C07C275/30 , C07D239/84 , C07D213/75 , C07D209/20 , C07C323/44 , C07D213/55
CPC分类号： C07C275/30 , C07C323/44 , C07D209/20 , C07D213/55 , C07D213/75 , C07D239/84
摘要： The present invention relates to novel aryl urea derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of the N-formyl peptide receptor like-1 (FPRL-1) receptor.
摘要翻译： 本发明涉及新的芳基脲衍生物，其制备方法，含有它们的药物组合物及其作为N-甲酰基肽受体1（FPRL-1）受体调节剂的药物的用途。
-
公开(公告)号：US20220202777A1
公开(公告)日：2022-06-30
申请号：US17229347
申请日：2021-04-13
申请人： Allergan, Inc.
IPC分类号： A61K31/417 , C07K5/062 , C07K5/078 , C07K5/072 , C07C275/30 , C07C317/42 , C07C323/44 , C07D209/20 , C07D233/64 , C07C317/50 , C07C323/60 , A61K31/17 , A61K31/197 , A61K31/216 , A61K31/4045 , A61K31/198
摘要： The present invention relates to novel amide derivatives of N-urea substituted amino acids, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of the N-formyl peptide receptor like-1 (FPRL-1) receptor.
-
公开(公告)号：US11046644B2
公开(公告)日：2021-06-29
申请号：US16410885
申请日：2019-05-13
申请人： ALLERGAN, INC.
发明人： Haiqing Yuan , Richard L. Beard , Xiaoxia Liu , John E. Donello , Veena Viswanath , Michael E. Garst
IPC分类号： C07C311/21 , C07D307/82 , C07C323/49 , C07C317/34 , C07D307/64 , C07C311/44 , A61K31/18 , A61K31/10 , A61P27/02 , C07F9/59 , C07C317/44 , C07C323/52 , C07C323/56 , C07C323/60 , C07D295/13 , C07D295/185 , C07D295/24 , C07F9/30 , C07F9/32 , C07F9/40 , C07F9/53 , C07F9/6533 , C07D233/64 , C07D405/12 , C07D413/12 , C07D417/12 , C07C317/36 , C07D213/52 , C07D333/34 , C07D277/40 , C07C317/42 , C07C317/50 , C07C323/67 , C07D213/32 , C07C321/30 , C07D207/09 , C07D207/46
摘要： The present invention relates to novel sulfur derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of chemokine receptors.
-
公开(公告)号：US10993931B2
公开(公告)日：2021-05-04
申请号：US16215400
申请日：2018-12-10
申请人： Allergan, Inc.
IPC分类号： C07C275/30 , C07C317/42 , C07C317/50 , C07C323/44 , C07C323/60 , A61K31/17 , A61K31/197 , A61K31/198 , A61K31/216 , A61K31/4045 , A61K31/417 , C07D209/20 , C07D233/64 , C07K5/062 , C07K5/072 , C07K5/078
摘要： The present invention relates to novel amide derivatives of N-urea substituted amino acids, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of the N-formyl peptide receptor like-1 (FPRL-1) receptor.
-
公开(公告)号：US10899780B2
公开(公告)日：2021-01-26
申请号：US16254438
申请日：2019-01-22
申请人： ALLERGAN, INC.
IPC分类号： A61K31/66 , A61K31/554 , A61K31/47 , A61K31/42 , A61K31/41 , A61K31/415 , C07F9/40 , C07C235/82 , C07C275/42 , C07D217/24 , C07D223/10 , C07D233/02 , C07D235/02 , C07D257/04 , C07D261/12 , C07D401/06 , C07D401/14 , C07D403/14 , C07D405/06 , C07D409/06 , A61K9/00 , A61K31/17 , A61K31/196 , A61K31/4166 , A61K31/662
摘要： The present invention relates to a method for treating ocular inflammatory diseases in a subject in need of such treatment, which comprises administering a pharmaceutical composition comprising a therapeutically effective amount of at least one agonist of Formyl peptide receptor 2.
-
公开(公告)号：US20200246360A1
公开(公告)日：2020-08-06
申请号：US16566682
申请日：2019-09-10
申请人： Allergan, Inc.
IPC分类号： A61K31/683 , A61K31/55 , A61K31/4725 , A61K31/472 , A61K31/4184 , A61K31/4178 , A61K31/4174 , A61K31/41 , A61K31/4045 , A61K31/192 , A61K31/167 , A61K9/00 , A61K31/662 , A61K31/42 , A61K31/4166 , A61K31/196 , A61K31/17 , A61P17/16 , A61P17/06 , A61P17/14 , A61P17/04 , A61P17/10 , A61P17/18 , A61P35/00 , A61P17/02 , A61P17/12 , C07D409/06 , C07D405/14 , C07D405/06 , C07D401/06 , C07D261/12 , C07D257/04 , C07D235/02 , C07D233/80 , C07D223/10 , C07D217/24 , C07C275/42 , C07C235/82 , C07F9/40 , A61P17/08
摘要： The present invention relates to a method for treating dermal inflammation and dermal diseases by local or systemic delivery, in a subject in need of such treatment, which comprises administering a pharmaceutical composition comprising a therapeutically effective amount of at least one agonist of Formyl peptide receptor 2 (FPR2).
-
29.发明申请公开(公告)号：US20190153004A1
公开(公告)日：2019-05-23
申请号：US16254438
申请日：2019-01-22
申请人： ALLERGAN, INC.
IPC分类号： C07F9/40 , C07D409/06 , A61K9/00 , C07D403/14 , C07D401/14 , C07D401/06 , C07D261/12 , C07D257/04 , C07D235/02 , C07D233/02 , C07D223/10 , C07D217/24 , C07C275/42 , C07C235/82 , C07D405/06 , A61K31/662 , A61K31/42 , A61K31/4166 , A61K31/196 , A61K31/17
摘要： The present invention relates to a method for treating ocular inflammatory diseases in a subject in need of such treatment, which comprises administering a pharmaceutical composition comprising a therapeutically effective amount of at least one agonist of Formyl peptide receptor 2.
-
公开(公告)号：US10251865B2
公开(公告)日：2019-04-09
申请号：US15813910
申请日：2017-11-15
申请人： Allergan, Inc.
IPC分类号： A61K31/415 , A61K31/4439 , A61K31/17 , A61K31/4164 , A61K31/421 , A61K31/4168 , A61K31/4178
摘要： Disclosed herein is a method of upregulating regulatory T-cells, and treating diseases that would benefit from such upregulation, by administering an alpha-2 receptor agonist.
-
-
-
-
-
-
-
-
-
搜索结果
80 条记录 (耗时 0.023 秒)
